Page last updated: 2024-11-07

penicillamine and Thrombophlebitis

penicillamine has been researched along with Thrombophlebitis in 1 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Thrombophlebitis: Inflammation of a vein associated with a blood clot (THROMBUS).

Research Excerpts

ExcerptRelevanceReference
"Although treatment has been well defined for childhood lead poisoning and for industrial lead exposure, the treatment of lead nephropathy has been poorly studied."3.65Chelation therapy in lead nephropathy. ( Morgan, JM, 1975)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morgan, JM1

Other Studies

1 other study available for penicillamine and Thrombophlebitis

ArticleYear
Chelation therapy in lead nephropathy.
    Southern medical journal, 1975, Volume: 68, Issue:8

    Topics: Acute Kidney Injury; Administration, Oral; Chelating Agents; Creatinine; Dimercaprol; Drug Eruptions

1975